HedgeMountain

683 Capital Management, LLC

New York, NY · CRD 156181
Hedge fund manager

683 Capital Management, LLC is an SEC-registered investment adviser based in New York, NY that reports managing 1 hedge fund on Form ADV. It reports $2.4 billion in regulatory assets under management. Its private funds, of all types, hold $2.4 billion in gross assets. Its disclosed U.S. stock holdings returned an estimated +4.4% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated +59.4% from Q3 2024 to Q2 2026, compared with +37.2% for the S&P 500, based on 13F filings.

Regulatory assets under management
$2.4 billionForm ADV Item 5.F
Gross assets of private funds
$2.4 billionAll private fund types, Form ADV
Hedge funds managed
11 private funds in total
Employees
10Form ADV Item 5.A
Registration
SEC-registered adviserCRD 156181
Latest Form ADV
03/30/2026Disciplinary disclosures: none reported

Estimated 13F portfolio performance

Est. 2026 YTD+4.4%Through Q2 2026 · S&P 500 +9.5%
Est. 2-year return+59.4%Q3 2024 – Q2 2026
S&P 500+37.2%Same quarters, price only
13F holdings$1.0 billion125 positions, 2026-06-30
$100$130$159Q3 2024Q1 2025Q3 2025Q1 202613F est. $159S&P 500 $137
QuarterEst. 13F returnS&P 500
Q2 2026+14.9%+14.8%
Q1 2026-9.1%-4.6%
Q4 2025+11.2%+2.4%
Q3 2025+23.0%+7.8%
Q2 2025+9.7%+10.4%
Q1 2025-8.0%-4.5%
Q4 2024-0.2%+2.1%
Q3 2024+10.8%+5.4%

Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures

Largest disclosed holdings

  • Capital One Finl Corp Com$73.2 million
  • Carvana Co$49.4 million
  • Anaptysbio Inc$44.6 million
  • Kaspi KZ JSC$40.7 million
  • Becton Dickinson & Co$37.8 million
  • Molina Healthcare Inc$37.7 million
  • Hilton Grand Vacations Inc Com$36.1 million
  • Protagonist Therapeutics Inc$35.5 million
  • Meiragtx Hldgs PLC$31.1 million
  • Wave Life Science$28.8 million

As of 2026-06-30, from 13F filing by 683 Capital Management, LLC.

From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. HedgeMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures